<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Biochemical Engineering</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11C45689-C208-49DC-A95B-1B971827AEB3"><gtr:id>11C45689-C208-49DC-A95B-1B971827AEB3</gtr:id><gtr:name>Merck &amp; Co Inc</gtr:name><gtr:address><gtr:line1>Merck &amp; Co Inc</gtr:line1><gtr:line2>One Merck Drive</gtr:line2><gtr:line4>Whitehouse Station</gtr:line4><gtr:line5>NJ 08889-0100</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A6AC24C-1A8A-4182-A443-95F24864DB56"><gtr:id>8A6AC24C-1A8A-4182-A443-95F24864DB56</gtr:id><gtr:name>Pfizer Global R and D</gtr:name><gtr:address><gtr:line1>Pfizer Global R and D</gtr:line1><gtr:line2>IPC475</gtr:line2><gtr:line3>Ramsgate Road</gtr:line3><gtr:line4>Sandwich</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT13 9NJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/56BA8849-9A0B-4CCE-A7CA-E8D1874A71BB"><gtr:id>56BA8849-9A0B-4CCE-A7CA-E8D1874A71BB</gtr:id><gtr:name>Pall Europe Ltd</gtr:name><gtr:address><gtr:line1>Europa House</gtr:line1><gtr:line2>Havant Street</gtr:line2><gtr:line4>Portsmouth</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>PO1 3PD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EDB67137-AF95-475C-954C-8EA1517069D6"><gtr:id>EDB67137-AF95-475C-954C-8EA1517069D6</gtr:id><gtr:name>Nat Inst for Bio Standards and Control</gtr:name><gtr:address><gtr:line1>Blanche Lane</gtr:line1><gtr:line2>South Mimms</gtr:line2><gtr:line4>Potters Bar</gtr:line4><gtr:line5>Hertfordshire</gtr:line5><gtr:postCode>EN6 3QG</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6D0FFC07-86C3-4570-95F6-26BD3A8EB89D"><gtr:id>6D0FFC07-86C3-4570-95F6-26BD3A8EB89D</gtr:id><gtr:name>Bio Products Laboratory</gtr:name><gtr:address><gtr:line1>Dagger Lane</gtr:line1><gtr:line4>Elstree</gtr:line4><gtr:line5>Herts</gtr:line5><gtr:postCode>WD6 3BX</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3CE01BF9-4D85-4CB7-AAFF-90B2AE789E1A"><gtr:id>3CE01BF9-4D85-4CB7-AAFF-90B2AE789E1A</gtr:id><gtr:name>UCB Celltech</gtr:name><gtr:address><gtr:line1>208 Bath Road</gtr:line1><gtr:line4>Slough</gtr:line4><gtr:postCode>SL1 3WE</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/069E6B1C-E60C-4B6B-967E-D9D705D26947"><gtr:id>069E6B1C-E60C-4B6B-967E-D9D705D26947</gtr:id><gtr:name>Eli Lilly and Company</gtr:name><gtr:address><gtr:line1>Eli Lilly and Company USA</gtr:line1><gtr:line2>Lilly Corporate Center</gtr:line2><gtr:line4>Indianapolis</gtr:line4><gtr:line5>Indiana</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B71B28E-4D2F-48DF-9C29-C84F667B8625"><gtr:id>7B71B28E-4D2F-48DF-9C29-C84F667B8625</gtr:id><gtr:name>GE (General Electric Company) UK</gtr:name><gtr:address><gtr:line1>The Ark, 201 Talgarth Rd</gtr:line1><gtr:line2>Hammersmith</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>W6 8BJ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02EBF3CC-79C4-47A3-990C-5E17BD091DF4"><gtr:id>02EBF3CC-79C4-47A3-990C-5E17BD091DF4</gtr:id><gtr:name>Eli Lilly and Company Limited</gtr:name><gtr:address><gtr:line1>Eli Lilly and Company Limited</gtr:line1><gtr:line2>Lilly Research Centre</gtr:line2><gtr:line3>Erl Wood Manor</gtr:line3><gtr:line4>Windlesham</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU20 6PH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8D55713A-87FD-4232-B50F-49BB01546C91"><gtr:id>8D55713A-87FD-4232-B50F-49BB01546C91</gtr:id><gtr:name>GE (General Electric Company)</gtr:name><gtr:address><gtr:line1>General Electric Company</gtr:line1><gtr:line2>3135 Easton Turnpike</gtr:line2><gtr:postCode>06828</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4F1D2F3A-756D-4BC2-9E81-091D0356FECB"><gtr:id>4F1D2F3A-756D-4BC2-9E81-091D0356FECB</gtr:id><gtr:name>TAP Biosystems</gtr:name><gtr:address><gtr:line1>York Way</gtr:line1><gtr:line2>Royston</gtr:line2><gtr:line3>Herts</gtr:line3><gtr:postCode>SG8 5WY</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F9352C90-5326-4908-BD9D-98AD79A3AC41"><gtr:id>F9352C90-5326-4908-BD9D-98AD79A3AC41</gtr:id><gtr:name>Protherics Plc</gtr:name><gtr:address><gtr:line1>Fourth Floor</gtr:line1><gtr:line2>3 Creed Court</gtr:line2><gtr:line3>5 Ludgate Hill</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>EC4M 7AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/45555183-99CB-4B93-BB81-CE9DDF06CF7E"><gtr:id>45555183-99CB-4B93-BB81-CE9DDF06CF7E</gtr:id><gtr:name>Lonza Biologics</gtr:name><gtr:address><gtr:line1>228 Bath Road</gtr:line1><gtr:line4>Slough</gtr:line4><gtr:postCode>SL1 4DX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6E492B30-A1FF-4AA9-9082-C98E01EC86FC"><gtr:id>6E492B30-A1FF-4AA9-9082-C98E01EC86FC</gtr:id><gtr:name>Wyeth USA</gtr:name><gtr:address><gtr:line1>Wyeth USA</gtr:line1><gtr:line2>5 Giralda Farms</gtr:line2><gtr:line4>Madison</gtr:line4><gtr:line5>NJ 07940</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF0020F8-9212-4670-ADC0-CBDFF5B93548"><gtr:id>DF0020F8-9212-4670-ADC0-CBDFF5B93548</gtr:id><gtr:name>GlaxoSmithKline</gtr:name><gtr:address><gtr:line1>Stockley Park West</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:postCode>UB11 1BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D0EAB664-9D19-46C7-9B2F-E89B0A027452"><gtr:id>D0EAB664-9D19-46C7-9B2F-E89B0A027452</gtr:id><gtr:name>Protherics UK Limted</gtr:name><gtr:address><gtr:line1>Blaenwaun</gtr:line1><gtr:line2>Ffostrasol</gtr:line2><gtr:line4>Llandysul</gtr:line4><gtr:line5>Wales</gtr:line5><gtr:postCode>SA44 5JT</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B10901DA-8B43-40E3-BC59-3FC15A8C2700"><gtr:id>B10901DA-8B43-40E3-BC59-3FC15A8C2700</gtr:id><gtr:name>Novasep SAS</gtr:name><gtr:address><gtr:line1>Site Eiffel</gtr:line1><gtr:line2>Boulevard de la Moselle</gtr:line2><gtr:line3>54340 Pompey</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A4C1518D-D229-4CD2-9267-CFD20D1D93B6"><gtr:id>A4C1518D-D229-4CD2-9267-CFD20D1D93B6</gtr:id><gtr:name>Intercell Biomedical Ltd</gtr:name><gtr:address><gtr:line1>Oakbank Park Road</gtr:line1><gtr:line2>Livingston</gtr:line2><gtr:postCode>EH53 0TG</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D92716D0-081B-4976-A3CF-2E591C175698"><gtr:id>D92716D0-081B-4976-A3CF-2E591C175698</gtr:id><gtr:name>Novo Nordisk A/S</gtr:name><gtr:address><gtr:line1>Hagedornsvej 1</gtr:line1><gtr:postCode>2820</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5FB700D0-6DE6-46B8-800F-4A1A213701B2"><gtr:id>5FB700D0-6DE6-46B8-800F-4A1A213701B2</gtr:id><gtr:name>Biovex Ltd</gtr:name><gtr:address><gtr:line1>70 Milton Park</gtr:line1><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX14 4RX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BB31CE5F-BF67-4C1A-88AF-D14E26E88E9D"><gtr:id>BB31CE5F-BF67-4C1A-88AF-D14E26E88E9D</gtr:id><gtr:name>Prometic Biosciences Ltd</gtr:name><gtr:address><gtr:line1>211 Cambridge Science Park</gtr:line1><gtr:line2>Milton Road</gtr:line2><gtr:postCode>CB4 0ZA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88051761-6C81-4292-ACAF-D3AD0C610862"><gtr:id>88051761-6C81-4292-ACAF-D3AD0C610862</gtr:id><gtr:name>MedImmune Ltd</gtr:name><gtr:address><gtr:line1>Milstein Building</gtr:line1><gtr:line2>Granta Park</gtr:line2><gtr:line3>Sir Aaron Klug Building</gtr:line3><gtr:postCode>CB21 6GH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D7F372DE-56FC-4B35-A155-5A2B3AFE2E43"><gtr:id>D7F372DE-56FC-4B35-A155-5A2B3AFE2E43</gtr:id><gtr:name>BioPharm Services Ltd</gtr:name><gtr:address><gtr:line1>1 Lexham Gardens</gtr:line1><gtr:line4>Amersham</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>HP6 5JP</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/07D5776B-9659-453F-A7A2-0AA2BBC0F6C7"><gtr:id>07D5776B-9659-453F-A7A2-0AA2BBC0F6C7</gtr:id><gtr:name>Avecia Limited</gtr:name><gtr:address><gtr:line1>PO Box 42</gtr:line1><gtr:line2>Hexagon House</gtr:line2><gtr:line3>Blackley</gtr:line3><gtr:postCode>M9 8ZS</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F0047698-07BE-4A1C-8E14-F04D9823C425"><gtr:id>F0047698-07BE-4A1C-8E14-F04D9823C425</gtr:id><gtr:name>BIA Seperations</gtr:name><gtr:address><gtr:line1>Teslova ulica 30</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Slovenia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B9542CC-D7F0-45DA-A423-16458386EA25"><gtr:id>5B9542CC-D7F0-45DA-A423-16458386EA25</gtr:id><gtr:name>GlaxoSmithKline PLC</gtr:name><gtr:address><gtr:line1>Park Road</gtr:line1><gtr:postCode>SG12 0DP</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1BC915E7-31F5-45FB-A6E8-CC7257BDA28C"><gtr:id>1BC915E7-31F5-45FB-A6E8-CC7257BDA28C</gtr:id><gtr:firstName>Frank</gtr:firstName><gtr:surname>Baganz</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C36FF9E2-9F9C-4F83-8FA0-CC4EB70340A3"><gtr:id>C36FF9E2-9F9C-4F83-8FA0-CC4EB70340A3</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Eames</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6FD51027-272A-4D4C-8DAD-097561016D16"><gtr:id>6FD51027-272A-4D4C-8DAD-097561016D16</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>L</gtr:otherNames><gtr:surname>Hart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D21E2EF8-F1F4-46B5-8134-2C2EE07CD45C"><gtr:id>D21E2EF8-F1F4-46B5-8134-2C2EE07CD45C</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Maxim</gtr:otherNames><gtr:surname>Ward</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A32B7873-1625-498B-8A41-2207600C34AB"><gtr:id>A32B7873-1625-498B-8A41-2207600C34AB</gtr:id><gtr:firstName>Nina</gtr:firstName><gtr:otherNames>Frances</gtr:otherNames><gtr:surname>Thornhill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FE21E034-520F-4046-BE23-34A2E7948AB5"><gtr:id>FE21E034-520F-4046-BE23-34A2E7948AB5</gtr:id><gtr:firstName>Gary</gtr:firstName><gtr:surname>Lye</gtr:surname><gtr:orcidId>0000-0002-6018-2091</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/566CF583-31F6-4263-B5D9-D64D9F244856"><gtr:id>566CF583-31F6-4263-B5D9-D64D9F244856</gtr:id><gtr:firstName>Y</gtr:firstName><gtr:surname>Zhou</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E6C33FD6-EF37-450A-BF45-79C8368A9A5B"><gtr:id>E6C33FD6-EF37-450A-BF45-79C8368A9A5B</gtr:id><gtr:firstName>Eli</gtr:firstName><gtr:surname>Keshavarz -Moore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0EAB19CE-E446-4D6D-86A5-0959FD9A5ED3"><gtr:id>0EAB19CE-E446-4D6D-86A5-0959FD9A5ED3</gtr:id><gtr:firstName>Nigel</gtr:firstName><gtr:surname>Titchener-Hooker</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/98BB23FC-2B93-48A0-B929-23AA0BDDC60B"><gtr:id>98BB23FC-2B93-48A0-B929-23AA0BDDC60B</gtr:id><gtr:firstName>Mike</gtr:firstName><gtr:surname>Hoare</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2E0BBB9D-2AE8-4368-A89A-665317171804"><gtr:id>2E0BBB9D-2AE8-4368-A89A-665317171804</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>Dalby</gtr:surname><gtr:orcidId>0000-0002-0980-8167</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A8ACADD2-6AB0-4C00-BE1E-C69D90DBBE5A"><gtr:id>A8ACADD2-6AB0-4C00-BE1E-C69D90DBBE5A</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>Gilbert</gtr:otherNames><gtr:surname>Bracewell</gtr:surname><gtr:orcidId>0000-0003-3866-3304</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/29F35B45-0BF2-4F52-905E-552188EC64A7"><gtr:id>29F35B45-0BF2-4F52-905E-552188EC64A7</gtr:id><gtr:firstName>Kerry</gtr:firstName><gtr:otherNames>Ann</gtr:otherNames><gtr:surname>Chester</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FE001599%2F1"><gtr:id>BC2FABB1-A154-4CAF-9693-DC2A10163C9D</gtr:id><gtr:title>IMRC for Bioprocessing</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/E001599/1</gtr:grantReference><gtr:abstractText>It is now widely accepted that up to ten years are needed to take a drug from discovery to availability for general healthcare treatment. This means that only a limited time is available where a company is able to recover its very high investment costs in making a drug available via exclusivity in the market and via patents. The next generation drugs will be even more complex and difficult to manufacture. If these are going to be available at affordable costs via commercially viable processes then the speed of drug development has to be increased while ensuring robustness and safety in manufacture. The research in this proposal addresses the challenging transition from bench to large scale where the considerable changes in the way materials are handled can severely affect the properties and ways of manufacture of the drug. The research will combine novel approaches to scale down with automated robotic methods to acquire data at a very early stage of new drug development. Such data will be relatable to production at scale, a major deliverable of this programme. Computer-based bioprocess modelling methods will bring together this data with process design methods to explore rapidly the best options for the manufacture of a new biopharmaceutical. By this means those involved in new drug development will, even at the early discovery stage, be able to define the scale up challenges. The relatively small amounts of precious discovery material needed for such studies means they must be of low cost and that automation of the studies means they will be applicable rapidly to a wide range of drug candidates. Hence even though a substantial number of these candidates may ultimately fail clinical trials it will still be feasible to explore process scale up challenges as safety and efficency studies are proceeding. For those drugs which prove to be effective healthcare treatments it will be possible then to go much faster to full scale operation and hence recoup the high investment costs.As society moves towards posing even greater demands for effective long-term healthcare, such as personalised medicines, these radical solutions are needed to make it possible to provide the new treatments which are going to be increasingly demanding to manufature.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>5913161</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The outputs regarding the successful development of ultra scale-down devices has been successfully taken up by a HEFCE funded programme to generate technology transfer (PI Prof Gary Lye</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>E786449D-5B64-4FAE-8CC0-32DBF9DA74FE</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56dea0764d4b49.77524600</gtr:outcomeId><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The methods enable more rapid progression from a life science discovery to a real viable process for manufucature.</gtr:description><gtr:exploitationPathways>Spin outs are in place and more planned via a HEFCE funded Technology transfer programme</gtr:exploitationPathways><gtr:id>4FAAD514-C570-4BA8-985A-EF4DC9B405A9</gtr:id><gtr:outcomeId>54623b06c4ed05.73806391</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Manufacturing, including Industrial Biotechology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of a guideline committee - Elected Management Board Member of BBSRC BioProNet (2015)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>84686A74-AB85-43B4-ACF5-70EF02C3EE2C</gtr:id><gtr:impact>BioProNet is key to advising and shaping the funding opportunities between BBSRC and EPSRC</gtr:impact><gtr:outcomeId>587cb3d04ae1a7.70376390</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EPSRC SAN</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0CA015D5-1EA1-42D8-90B6-6D217673F652</gtr:id><gtr:impact>The EPSRC SAN is instrumental in helping the Council to formulate its research funding priorities</gtr:impact><gtr:outcomeId>587cb34bcf0ba1.71159353</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>CE marked devices (10s mL scale) to mimic the process engineering environment to which biological materials are exposed during large scale manufacture , especially of therapeutics. 
For example a USD shear device, a USD membrane device 
Andrea CME Rayat, Alex Chatel, Mike Hoare, Gary J Lye, Ultra scale-down approaches to enhance the creation of bioprocesses at scale: impacts of process shear stress and early recovery stages, Current Opinion in Chemical Engineering, Volume 14, November 2016, Pages 150-157, ISSN 2211-3398, http://dx.doi.org/10.1016/j.coche.2016.09.012</gtr:description><gtr:id>BEBA2549-CCEE-4577-BC9D-3DAFBE3310A0</gtr:id><gtr:impact>Prediction for processing mammalian cell broths in industrial continuous flow centrifuges
Maximising recovery of novel vaccines.

CE marked devices provided largely to researchers in bioprocessing industry via research collaborations</gtr:impact><gtr:outcomeId>58bec37b010933.90876838</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Ultra scale-down (USD) technologies</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Puridify</gtr:companyName><gtr:description>Puridify's technology, FibroSelect - a novel chromatography reagent, offers significant advantages across key performance attributes that not only allow chromatography associated costs to be reduced by up to 90% but are also well aligned to meet the industry demands today and as the market evolves.</gtr:description><gtr:id>725E946E-3A4A-4F66-B236-4777E1E51C04</gtr:id><gtr:impact>Puridify have proven at research scale (0.2mL reagent) that their technology can operate at 50x throughput due to better permeability and fast mass transfer. This improves process economics by increasing productivity and is also beneficial when processing labile products. The reagent has shown better resistance than our competitors to impurity fouling and cleaning steps, a common cause of performance degradation over multiple cycles. The technology allows cheap and rapid bioprocess development due to uniform performance at all scales, promoting its adoption in industry.</gtr:impact><gtr:outcomeId>5416ffa592e251.20367268</gtr:outcomeId><gtr:url>http://puridify.com/</gtr:url><gtr:yearCompanyFormed>2013</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>6AFE0E77-6A64-415F-953C-64FE95364BA5</gtr:id><gtr:title>Design of high productivity antibody capture by protein A chromatography using an integrated experimental and modeling approach.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be8edb1cca9ea612e3da21b3d8d615dd"><gtr:id>be8edb1cca9ea612e3da21b3d8d615dd</gtr:id><gtr:otherNames>Ng CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1570-0232</gtr:issn><gtr:outcomeId>54523f7b5b08b4.08724382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>772BE7CD-7843-4BC6-B32D-B12ABE11CE5F</gtr:id><gtr:title>Fouling of an anion exchange chromatography operation in a monoclonal antibody process: Visualization and kinetic studies.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1adc24a1799922082d1d5bc9c9505bd"><gtr:id>e1adc24a1799922082d1d5bc9c9505bd</gtr:id><gtr:otherNames>Close EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>54523f7a05d948.79536272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DCC37E1-3392-4F84-A127-F0177304CA88</gtr:id><gtr:title>An ultra-scale down study of the separation of flocculated E. Coli extract in a disc-stack centrifuge</gtr:title><gtr:parentPublicationTitle>AIChE Annual Meeting, Conference Proceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f69a7818e4b912af503d1463de19e84"><gtr:id>8f69a7818e4b912af503d1463de19e84</gtr:id><gtr:otherNames>Berrill A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>54523f7cca31c6.80729230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCD35A0B-F408-499C-BA7B-89F24D70A77A</gtr:id><gtr:title>The release of single cells from embryoid bodies in a capillary flow device</gtr:title><gtr:parentPublicationTitle>Chemical Engineering Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b36dc6374959aa5914317e4715b7924f"><gtr:id>b36dc6374959aa5914317e4715b7924f</gtr:id><gtr:otherNames>Papantoniou I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>5461edcb7010e5.72342138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>570A8ED0-81B6-40CE-A921-079F702AA6B6</gtr:id><gtr:title>Dual salt precipitation for the recovery of a recombinant protein from Escherichia coli.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6135f86398cc0e44282326d67ad2d604"><gtr:id>6135f86398cc0e44282326d67ad2d604</gtr:id><gtr:otherNames>Balasundaram B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f7aadf631.15483169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>988A6E3E-F6D9-4640-A9BC-5081EDE78EF8</gtr:id><gtr:title>Mimic of a large-scale diafiltration process by using ultra scale-down rotating disc filter.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/198882029ebb90d27d66ece143fb4da0"><gtr:id>198882029ebb90d27d66ece143fb4da0</gtr:id><gtr:otherNames>Ma G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>5461edca34b995.83063344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31FF4FED-6865-4A7B-9DBB-FAE6336E85E6</gtr:id><gtr:title>Evaluation of the impact of lipid fouling during the chromatographic purification of virus-like particles from</gtr:title><gtr:parentPublicationTitle>Journal of Chemical Technology &amp; Biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40adf277cdebdaa1cceb57dd629a1437"><gtr:id>40adf277cdebdaa1cceb57dd629a1437</gtr:id><gtr:otherNames>Jin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>54523f7a87f0a8.48682948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22E56CAE-7227-46EE-A55C-437EA5BD6906</gtr:id><gtr:title>Ultra scale-down approach to correct dispersive and retentive effects in small-scale columns when predicting larger scale elution profiles.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7cae723aedd93f7826774ca0a3ede02"><gtr:id>b7cae723aedd93f7826774ca0a3ede02</gtr:id><gtr:otherNames>Hutchinson N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>546288056bca21.85536044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24A1C304-8BF5-4B1B-A467-FACCD10A76D7</gtr:id><gtr:title>Chromatography modelling to describe protein adsorption at bead level.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d9730abefad3e23e8f5a96c64934a3d"><gtr:id>1d9730abefad3e23e8f5a96c64934a3d</gtr:id><gtr:otherNames>Gerontas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9673</gtr:issn><gtr:outcomeId>54523f7bd16959.90183325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15DAF84C-0AFF-4F26-8EC7-B3D8CC16A6C7</gtr:id><gtr:title>An Intelligent Automation Platform for Rapid Bioprocess Design.</gtr:title><gtr:parentPublicationTitle>Journal of laboratory automation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e73beee53b331feed1446adc0ac5d90a"><gtr:id>e73beee53b331feed1446adc0ac5d90a</gtr:id><gtr:otherNames>Wu T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2211-0682</gtr:issn><gtr:outcomeId>56e171e1e78b11.15377954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F02A3286-F0B2-40B2-B8C6-6C6E4A528C37</gtr:id><gtr:title>Nanofibre fabrication in a temperature and humidity controlled environment for improved fibre consistency</gtr:title><gtr:parentPublicationTitle>Journal of Materials Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f98cd3ef65d3948e6ae5b0ebd16ecf77"><gtr:id>f98cd3ef65d3948e6ae5b0ebd16ecf77</gtr:id><gtr:otherNames>Hardick O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>54523f78380b38.77802168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51C33005-4DE4-4196-BCBB-0F0B0C090B4D</gtr:id><gtr:title>Study of the conditions for multi-modal chromatographic capture of Fab' from dual-salt precipitated
 
 homogenate</gtr:title><gtr:parentPublicationTitle>Journal of Chemical Technology &amp; Biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6135f86398cc0e44282326d67ad2d604"><gtr:id>6135f86398cc0e44282326d67ad2d604</gtr:id><gtr:otherNames>Balasundaram B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>54523f759b62d6.48947897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF92B7E9-5730-47B4-B668-8C41036D8834</gtr:id><gtr:title>Modelling of industrial biopharmaceutical multicomponent chromatography</gtr:title><gtr:parentPublicationTitle>Chemical Engineering Research and Design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fcb135297ca010fbb1c8f54f62c1c08"><gtr:id>7fcb135297ca010fbb1c8f54f62c1c08</gtr:id><gtr:otherNames>Close E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54523f788e1740.45077167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCD8BB86-F5D0-4FA6-86D5-715BF3E90F7D</gtr:id><gtr:title>Principal component score modeling for the rapid description of chromatographic separations.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22f3f0d228dce1bdfa1002ea43488eaf"><gtr:id>22f3f0d228dce1bdfa1002ea43488eaf</gtr:id><gtr:otherNames>Edwards-Parton S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f777f3677.35140636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69F54B41-40A9-420F-B1E6-0E7A967382D6</gtr:id><gtr:title>Protein denaturation and protein:drugs interactions from intrinsic protein fluorescence measurements at the nanolitre scale.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dcdf0fca36ee0227a43b3b54739c7d9"><gtr:id>4dcdf0fca36ee0227a43b3b54739c7d9</gtr:id><gtr:otherNames>Gaudet M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>54523f76f28f35.35692022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>813B2546-A61A-4FF4-8BCA-43869AE3F13D</gtr:id><gtr:title>A microscale approach for predicting the performance of chromatography columns used to recover therapeutic polyclonal antibodies.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29fbac184681cef8193fe80a5dade52"><gtr:id>a29fbac184681cef8193fe80a5dade52</gtr:id><gtr:otherNames>Chhatre S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9673</gtr:issn><gtr:outcomeId>54523f7e801af0.80265825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B44CAA1B-1ED3-41FD-A087-4B2C07FBDC5A</gtr:id><gtr:title>Study of a novel tube forming method for preparing engineered blood vessels</gtr:title><gtr:parentPublicationTitle>Chemical Engineering Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d98c2be629a44881cbb7970d76e16165"><gtr:id>d98c2be629a44881cbb7970d76e16165</gtr:id><gtr:otherNames>Eames I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>5461edcb932931.86741146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D341EFFE-E46D-4918-8089-FEE661503C2B</gtr:id><gtr:title>Exploiting the intracellular compartmentalization characteristics of the S. cerevisiae host cell for enhancing primary purification of lipid-envelope virus-like particles.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e92a63a7e12daf0f6bc9135b253ae8e9"><gtr:id>e92a63a7e12daf0f6bc9135b253ae8e9</gtr:id><gtr:otherNames>Kee GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f7a5f7580.20040794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54CC74D7-EBF0-4ED0-AABC-960E5F878EB2</gtr:id><gtr:title>Assessment of the manufacturability of Escherichia coli high cell density fermentations.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4ab249773ad8712a26dea6eef0b38a2"><gtr:id>c4ab249773ad8712a26dea6eef0b38a2</gtr:id><gtr:otherNames>Perez-Pardo MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f7ca45b11.89623704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB810459-7396-4BEF-A123-EEFDB3D0EB6B</gtr:id><gtr:title>Impact of clarification strategy on chromatographic separations: Pre-processing of cell homogenates.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94239f028126d0ed80ee49952edff9e4"><gtr:id>94239f028126d0ed80ee49952edff9e4</gtr:id><gtr:otherNames>Bracewell DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>54523f79788048.44218768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ACA5AED-2A9A-41DD-A4A9-F664BEBC61FD</gtr:id><gtr:title>The Hybrid Experimental Simplex Algorithm for ?sweet spot? identification in early bioprocess development: Applications, Challenges, Recommendations.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d57a111e6c8312d6e9645c2effba9bd"><gtr:id>7d57a111e6c8312d6e9645c2effba9bd</gtr:id><gtr:otherNames>S Konstantinidis (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_89157063951404f308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38614118-B68D-4383-983C-6AE99FB07DA2</gtr:id><gtr:title>Product and contaminant measurement in bioprocess development by SELDI-MS.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80c45bfc427911487254d08c54769c5e"><gtr:id>80c45bfc427911487254d08c54769c5e</gtr:id><gtr:otherNames>Berrill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f77596b67.83487567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64E9E1D0-A180-4F0F-B5CD-755D555926F9</gtr:id><gtr:title>Understanding the relationship between biotherapeutic protein stability and solid-liquid interfacial shear in constant region mutants of IgG1 and IgG4.</gtr:title><gtr:parentPublicationTitle>Journal of pharmaceutical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e29b6c2a2294507e76788bce8720f4f9"><gtr:id>e29b6c2a2294507e76788bce8720f4f9</gtr:id><gtr:otherNames>Tavakoli-Keshe R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3549</gtr:issn><gtr:outcomeId>54523f75219926.16671954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EC2E384-76BB-4933-B202-80D4E472A115</gtr:id><gtr:title>Integration of scale-down experimentation and general rate modelling to predict manufacturing scale chromatographic separations.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d9730abefad3e23e8f5a96c64934a3d"><gtr:id>1d9730abefad3e23e8f5a96c64934a3d</gtr:id><gtr:otherNames>Gerontas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9673</gtr:issn><gtr:outcomeId>54523f7945dd99.03919024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>783F57CD-937C-40CC-ABC8-F0C93096696E</gtr:id><gtr:title>Mathematical Modelling of Protein Precipitation Based on the Phase Equilibrium for an Antibody Fragment from E. coli Lysis</gtr:title><gtr:parentPublicationTitle>Journal of Bioprocessing &amp; Biotechniques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c2a4af9f42a88efefb696767d62dd9"><gtr:id>07c2a4af9f42a88efefb696767d62dd9</gtr:id><gtr:otherNames>Zhou Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56e1721a3c4736.97354068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A60FA6FA-EAAA-49CF-874E-3EF79FDC9470</gtr:id><gtr:title>Use of focused acoustics for cell disruption to provide ultra scale-down insights of microbial homogenization and its bioprocess impact--recovery of antibody fragments from rec E. coli.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99f6924f8765fc02490873fd4b290945"><gtr:id>99f6924f8765fc02490873fd4b290945</gtr:id><gtr:otherNames>Li Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>5461edca58b5a9.10747612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C137C88-A379-4D5E-AB42-E8B040429704</gtr:id><gtr:title>Microfluidic Chromatography for Early Stage Evaluation of Biopharmaceutical Binding and Separation Conditions</gtr:title><gtr:parentPublicationTitle>Separation Science and Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75eb5b5a049ddc6e8f8f9bf6f80acde5"><gtr:id>75eb5b5a049ddc6e8f8f9bf6f80acde5</gtr:id><gtr:otherNames>Shapiro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>54523f78b75aa5.03245244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>096BA677-E7A5-4A19-A65A-516A9D226661</gtr:id><gtr:title>A logic-reasoning based system to harness bioprocess experimental data and knowledge for design</gtr:title><gtr:parentPublicationTitle>Biochemical Engineering Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f5ff2310b21823fdc45326aba6a7d2d"><gtr:id>6f5ff2310b21823fdc45326aba6a7d2d</gtr:id><gtr:otherNames>Zhang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56e1725f46fd93.42763314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6DBEE7D-CF03-4919-BE12-409FD6419B23</gtr:id><gtr:title>Factors influencing antibody stability at solid-liquid interfaces in a high shear environment.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce060795a5453a1420ed01fe1458888a"><gtr:id>ce060795a5453a1420ed01fe1458888a</gtr:id><gtr:otherNames>Biddlecombe JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f7a34b683.42506076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC4D3056-7C3F-48F3-BD8F-31D9FA21F1E5</gtr:id><gtr:title>Chemical and biological characterisation of a sensor surface for bioprocess monitoring.</gtr:title><gtr:parentPublicationTitle>Biosensors &amp; bioelectronics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4cc10c55bd7178f0da0b3c21d7e70fb"><gtr:id>a4cc10c55bd7178f0da0b3c21d7e70fb</gtr:id><gtr:otherNames>Moore JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0956-5663</gtr:issn><gtr:outcomeId>54523f7c0526d0.07782583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CDA1487-2A71-4E3B-ABED-A2645B7EBDE5</gtr:id><gtr:title>A microscale yeast cell disruption technique for integrated process development strategies.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69b524d31757e6b878f842d3488c4a98"><gtr:id>69b524d31757e6b878f842d3488c4a98</gtr:id><gtr:otherNames>Wenger MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f7e596809.09097062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02BFF040-6C66-4D69-8F56-B2EF0C65B751</gtr:id><gtr:title>Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dff8199fec6dbd0350e8f93dc486863d"><gtr:id>dff8199fec6dbd0350e8f93dc486863d</gtr:id><gtr:otherNames>Pollock J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9673</gtr:issn><gtr:outcomeId>54523f78046473.03482684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62FCEFA2-EDF4-41E8-98EE-90E691797650</gtr:id><gtr:title>Regenerative medicine bioprocessing: concentration and behavior of adherent cell suspensions and pastes.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf59eb564b871a6ed1069c8aaaaa55bf"><gtr:id>bf59eb564b871a6ed1069c8aaaaa55bf</gtr:id><gtr:otherNames>Zoro BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>5461edcb4be1d6.32630485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B44308D8-64F8-406A-B3FB-68113790B0E8</gtr:id><gtr:title>Chromatography modelling at bead level for bioprocess design and understanding</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c369b745c483f946d7b2fa67ba7f546d"><gtr:id>c369b745c483f946d7b2fa67ba7f546d</gtr:id><gtr:otherNames>Daniel  Bracewell (Co-author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_503658877613dd0d8e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EBAE527-93D8-4228-A632-85467757C4DF</gtr:id><gtr:title>Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79afc91f579d36601aaf09078d6cd7bb"><gtr:id>79afc91f579d36601aaf09078d6cd7bb</gtr:id><gtr:otherNames>Reid CQ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>5461ea83221491.18081965</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DC8F75F-7845-4346-AFB9-42DD713A3E61</gtr:id><gtr:title>Mass spectrometry to describe product and contaminant adsorption properties for bioprocess development.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80c45bfc427911487254d08c54769c5e"><gtr:id>80c45bfc427911487254d08c54769c5e</gtr:id><gtr:otherNames>Berrill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>54523f78de4357.38058328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AD4F2BC-5E86-4392-99AC-2E5F8F6F84B7</gtr:id><gtr:title>The use of an automated multiwell filtration technique for mammalian cell removal and clarification studies</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4916d140694dbdfa6cd6d86162cef6f1"><gtr:id>4916d140694dbdfa6cd6d86162cef6f1</gtr:id><gtr:otherNames>AS Tait</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>r_2712688763cac82fe6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40A682DE-5936-4EAE-B22C-58D7380441BA</gtr:id><gtr:title>Characterization and feasibility of a miniaturized stirred tank bioreactor to perform E. coli high cell density fed-batch fermentations.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fffc67a4c7eec4e83a1fa42feaa78ef"><gtr:id>2fffc67a4c7eec4e83a1fa42feaa78ef</gtr:id><gtr:otherNames>Ali S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f7c2b5011.87402581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>178C112C-C8FD-4308-ABD1-B70BC6967E66</gtr:id><gtr:title>An ultra scale-down approach to study the interaction of fermentation, homogenization, and centrifugation for antibody fragment recovery from rec E. coli.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99f6924f8765fc02490873fd4b290945"><gtr:id>99f6924f8765fc02490873fd4b290945</gtr:id><gtr:otherNames>Li Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>5461edca79a9d0.07753218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1022C5D1-AAE4-4736-AF64-0092008F239D</gtr:id><gtr:title>Ultra scale-down stress analysis of the bioprocessing of whole human cells as a basis for cancer vaccines.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62c6c2068dcf7b8d5ae969cdc2c85c44"><gtr:id>62c6c2068dcf7b8d5ae969cdc2c85c44</gtr:id><gtr:otherNames>Acosta-Martinez JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>5461ee2f46e917.02602794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>667E52FA-29CB-461F-91D0-C84039475C37</gtr:id><gtr:title>Methods for rapid process characterisation in the successful translation of process technologies</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1632a18e0daed7844a229dc28c5ac7a9"><gtr:id>1632a18e0daed7844a229dc28c5ac7a9</gtr:id><gtr:otherNames>Nigel Titchener-Hooker (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>m_821934350213f46448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C9D7A1F-7310-4C3F-9E9C-0C424D175613</gtr:id><gtr:title>Investigating the use of column inserts to achieve better chromatographic bed support.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe98462ae987560f10c37021698c0e81"><gtr:id>fe98462ae987560f10c37021698c0e81</gtr:id><gtr:otherNames>Lan T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>545de29a229357.23238915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F020098-72D5-4A1C-A0A2-F1417CFF101C</gtr:id><gtr:title>Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67983f368996498a0435fab9443117fb"><gtr:id>67983f368996498a0435fab9443117fb</gtr:id><gtr:otherNames>Abe Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>54523f7910d428.74398288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>249B1BDB-4F59-4689-8FE8-E76516AF0BCF</gtr:id><gtr:title>Nanofiber adsorbents for high productivity downstream processing.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f98cd3ef65d3948e6ae5b0ebd16ecf77"><gtr:id>f98cd3ef65d3948e6ae5b0ebd16ecf77</gtr:id><gtr:otherNames>Hardick O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>54523f786327f3.71374502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42AF83F6-FB5B-47E8-B63C-8FEBC551F78D</gtr:id><gtr:title>An ultra scale-down characterisation of primary recovery stages to enhance selectivity of fusion protein recovery from its molecular variants</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deaae5de29306af070c6d160bfbd4266"><gtr:id>deaae5de29306af070c6d160bfbd4266</gtr:id><gtr:otherNames>A Mcilgorm</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_5656987441cac2585a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF7BF965-7A47-4B30-8E29-0F252F4F804F</gtr:id><gtr:title>Ultra scale-down to define and improve the relationship between flocculation and disc-stack centrifugation.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80c45bfc427911487254d08c54769c5e"><gtr:id>80c45bfc427911487254d08c54769c5e</gtr:id><gtr:otherNames>Berrill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn><gtr:outcomeId>54523f75489d98.09936964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B967BD7-1D51-40FC-8C11-3D15599E38B9</gtr:id><gtr:title>Hybrid experimental simplex algorithm, a novel optimization method for high throughput experimentation: Case studies in ion exchange chromatography</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f16fc536bfab1f33902297d66caaed3"><gtr:id>3f16fc536bfab1f33902297d66caaed3</gtr:id><gtr:otherNames>S Konstantinidis  (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_66205409671404f25e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15E00DE6-DB5A-46A1-B837-812D3573ECED</gtr:id><gtr:title>Peptide and Protein Delivery</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80c45bfc427911487254d08c54769c5e"><gtr:id>80c45bfc427911487254d08c54769c5e</gtr:id><gtr:otherNames>Berrill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>9780123849359</gtr:isbn><gtr:outcomeId>54523f772db3e0.95998774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0F36973-2DD1-499B-B9D0-0CC8E995665D</gtr:id><gtr:title>Design of high productivity sequential multi-column chromatography for antibody capture</gtr:title><gtr:parentPublicationTitle>Food and Bioproducts Processing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac628a982dc20a0bc65978160f80be0a"><gtr:id>ac628a982dc20a0bc65978160f80be0a</gtr:id><gtr:otherNames>Ng C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54523f7b33d211.49522189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7D20FB7-837A-49BA-A818-C0BABE057838</gtr:id><gtr:title>Microwell-based ultra scale-down approaches for the selection of primary recovery operations</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4916d140694dbdfa6cd6d86162cef6f1"><gtr:id>4916d140694dbdfa6cd6d86162cef6f1</gtr:id><gtr:otherNames>AS Tait</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_4397474855cac58e30</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10B8336C-77FD-46EA-8751-A3C83808FBB5</gtr:id><gtr:title>Abandoning Geometric Rules ? the Evolution of Ultra Scale-Down</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1632a18e0daed7844a229dc28c5ac7a9"><gtr:id>1632a18e0daed7844a229dc28c5ac7a9</gtr:id><gtr:otherNames>Nigel Titchener-Hooker (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_920946688713f4615a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD0FCFB5-6D50-4B01-99B2-87B815F40F7D</gtr:id><gtr:title>A monolith purification process for virus-like particles from yeast homogenate.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8698a724c70e500cc0272fdf019f21a"><gtr:id>a8698a724c70e500cc0272fdf019f21a</gtr:id><gtr:otherNames>Burden CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1570-0232</gtr:issn><gtr:outcomeId>54523f7dda49e1.12356670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63A34067-6F8A-42E8-9F75-F9A30A2CE24D</gtr:id><gtr:title>A model based approach for identifying robust operating conditions for industrial chromatography with process variability</gtr:title><gtr:parentPublicationTitle>Chemical Engineering Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fcb135297ca010fbb1c8f54f62c1c08"><gtr:id>7fcb135297ca010fbb1c8f54f62c1c08</gtr:id><gtr:otherNames>Close E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54523f7e322064.82886088</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/E001599/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>99E0B904-CAB5-4511-AFB3-AA6D2B171F97</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Process engineering</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>86C61AF7-DC51-4A18-9679-D0EFD3860BFF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Design of Process systems</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>